Acetazolamide is used to treat glaucoma (high pressure in the eye), prevent altitude sickness when traveling to high elevations, and help reduce excess fluid in the body in conditions like heart failure or epilepsy.[2] Diamox is currently approved and in use across 56 indications[4].[1]
Diamox is one of 1107 small molecule programs targeting Angle-Closure Glaucoma. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
797 competitors in Hepatocellular Carcinoma
Diamox
Cysteine Hydrochloride
Ibrance
Hepsera
Apatinib
Doptelet
Miraclid
Vermox
PD-1 Inhibitor
QL1706
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
DIAMOX
NDA NDA012945
Jan 1, 1982
DIAMOX
NDA NDA009388
Jan 1, 1982
DIAMOX
NDA NDA008943
Sources